- Home
- HNNA vs LXEO Comparison
HNNA vs LXEO Comparison
Compare HNNA & LXEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HNNA
- LXEO
- Stock Information
- Founded
- HNNA 1989
- LXEO 2017
- Country
- HNNA United States
- LXEO United States
- Employees
- HNNA N/A
- LXEO N/A
- Industry
- HNNA Investment Managers
- LXEO
- Sector
- HNNA Finance
- LXEO
- Exchange
- HNNA Nasdaq
- LXEO Nasdaq
- Market Cap
- HNNA 86.4M
- LXEO 93.9M
- IPO Year
- HNNA N/A
- LXEO 2023
- Fundamental
- Price
- HNNA $12.35
- LXEO $4.45
- Analyst Decision
- HNNA
- LXEO Strong Buy
- Analyst Count
- HNNA 0
- LXEO 5
- Target Price
- HNNA N/A
- LXEO $16.60
- AVG Volume (30 Days)
- HNNA 7.8K
- LXEO 651.3K
- Earning Date
- HNNA 08-07-2025
- LXEO 08-11-2025
- Dividend Yield
- HNNA 4.45%
- LXEO N/A
- EPS Growth
- HNNA 83.55
- LXEO N/A
- EPS
- HNNA 1.25
- LXEO N/A
- Revenue
- HNNA $35,546,000.00
- LXEO N/A
- Revenue This Year
- HNNA N/A
- LXEO N/A
- Revenue Next Year
- HNNA N/A
- LXEO N/A
- P/E Ratio
- HNNA $9.88
- LXEO N/A
- Revenue Growth
- HNNA 41.94
- LXEO N/A
- 52 Week Low
- HNNA $7.10
- LXEO $1.45
- 52 Week High
- HNNA $13.88
- LXEO $19.50
- Technical
- Relative Strength Index (RSI)
- HNNA 77.45
- LXEO 62.69
- Support Level
- HNNA $10.86
- LXEO $3.91
- Resistance Level
- HNNA $12.73
- LXEO $4.50
- Average True Range (ATR)
- HNNA 0.48
- LXEO 0.36
- MACD
- HNNA 0.11
- LXEO 0.01
- Stochastic Oscillator
- HNNA 97.64
- LXEO 94.32
About HNNA Hennessy Advisors Inc.
Hennessy Advisors Inc is an investment management company, engaged in the managing and marketing of open-end mutual funds branded as the Hennessy Funds. It offers domestic equity, sectors, and specialty, balanced, and fixed income products. It also provides investment advisory services and shareholder services to the Hennessy Funds which include managing the composition of each fund's portfolio, including the purchase, retention, and disposition of portfolio securities as per the Fund's investment objectives, policies, and restrictions; conducting investment research, and monitoring compliance with each fund's investment restrictions and applicable laws and regulations.
About LXEO Lexeo Therapeutics Inc.
Lexeo Therapeutics Inc is a clinical-stage genetic medicines company committed to transforming healthcare by applying pioneering science to fundamentally alter how diseases are treated. The company focuses on preclinical and clinical stage gene therapies, specifically hereditary and acquired diseases with high unmet needs, which represent its sole business segment.